Brief: Theranexus Reports Inclusion Of Last Patient In Phase II Trial For THN102

Thx Pharma SA

24/09/2019 17:52

Sept 24 (Reuters) - THERANEXUS SA  ALTHX.PA :
    * A NEW MILESTONE REACHED FOR THERANEXUS: INCLUSION OF LAST
PATIENT IN PHASE II TRIAL FOR THN102 IN PARKINSON'S PATIENTS
    * TRIAL RESULTS EXPECTED IN Q1 2020
    * THIS TRIAL CONDUCTED IN EUROPE AND UNITED STATES EVALUATES
TOLERANCE AND EFFICACY OF THN102 ON NON-MOTOR SYMPTOMS IN
PARKINSON'S DISEASE PATIENTS

Source text for Eikon:  ID:nACT60259 
Further company coverage:  ALTHX.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com;))